Raymond A Miller
@RayMillerIP
IP Attorney trying to integrate all facets of exclusivity to advance #innovation. Host of #RaysRetreat. Inventor, legal advisor to biotechs, science geek.
You might like
Wet signatures are important! When notaries fail to fulfill their duties during in-person or remote notarizations, fraudsters may succeed – Check out the lessons learned from Fang vs. Nexus Development Holdings. #dlapiper sprou.tt/1vs5JGWAu76
Honored to be included in IAM Patent 1000 and IAM Strategy 300. Pleased to see my collaborator Nicole Stakleff also recognized. I appreciate the acknowledgment.
Raymond Miller and Nicole Stakleff have been named to the ninth edition of @IAM_magazine Patent 1000, a list of the world’s leading #patent professionals. Miller was also included in the IAM Strategy 300. #patentlaw #intellectualproperty troutman.com/insights/iam-p…
It was a great night spending time with past and future attendees of #RaysRetreat. Can't wait to see you all on the island. @PepperHealth @Pepper_Law @jpmorgan Healthcare Conference
Presenting for final time at #Dermatology Summit @PepperHealth in advance of @jpmorgan Healthcare Conference as @Pepper_Law. This time next year we will be here as Troutman Pepper. This newly formed firm will have over 1,100+ lawyers across 23 U.S. offices.
Our #ASDSMeeting panel had a great group of innovators—Mathew Avram, dir. of @MassGeneralNews #Dermatology Laser & Cosmetic Ctr, @DrLilitGaribyan, Bill Humphries, prez of Ortho Dermatologics, Dieter Manstein, inventor of @CoolSculpting & Mike Peterson, CTO @MerzGlobal N. America.
We had a great panel on #innovation in #dermatology last night at the @ASDSmembers meeting with @DrJCarruthers, “mother of Botox.” Thanks to Dr. Lynn Drake of @MassGeneralNews & Frederick Beddingfield, CEO of @SiennaBio, for inviting me. #ASDSMeeting
Proud of the work my #IP partner Howard Shire is doing on this matter. This is a great example of Pepper's creative approach to protecting IP of all sizes and shapes. pepperlaw.com/news/pepper-ha…
Excited to be representing @PepperHealth at the @SocInvestDerm annual meeting today in Chicago. I spoke about the importance of #IP at this gathering of innovators in #dermatology.
Thanks to our friends at Almirall for hosting us at their facilities in Barcelona today. We enjoyed discussing #IP and the company's innovative research in the #dermatology field. Gràcies!
The @PepperHealth European tour continues today as my partner Nicole Stakleff and I spoke about #IP and #healthcare at the @HGF_IP conference, hosted at London's @rcgp. Thanks to all who attended today and earlier this week in Manchester!
Unbelievably proud of Pepper client @ArielMedicine for winning Emerging Companynof Year award at this year’s @LifeSciencesPA - keep working Jessica, Tory and the entire Ariel team! You demonstrate why having an integrated @PepperHealth team is so important!
Nicole Stakleff building, leading, and inspiring at Women In Bio in Pittsburgh #WIB @PepperHealth @WIBPittsburgh @Pepper_Law
Great analysis of Theranos IP position. Certainly emphasizes the need for critical diligence at all stages of a development in a life science company. The granting of a patent is just the beginning. The system isn’t broken - the investors and IP lawyers need to ask questions
This article is also a very good argument for investors to look closely at the patents of the start-ups they are giving money to. They are key assets and need to be treated as such. That means a deep dive, not a casual glance. arstechnica.com/tech-policy/20…
Rodan, Stakleff, Fields + Miller last night at a great dinner with a great client. @RodanFieldsHQ #dermatology #IP
Great takeaways from my colleagues on developing an integrated #IP strategy for #lifesciences companies.
This article is also a very good argument for investors to look closely at the patents of the start-ups they are giving money to. They are key assets and need to be treated as such. That means a deep dive, not a casual glance. arstechnica.com/tech-policy/20…
Great job Rachael! Congratulations!
This article is also a very good argument for investors to look closely at the patents of the start-ups they are giving money to. They are key assets and need to be treated as such. That means a deep dive, not a casual glance. arstechnica.com/tech-policy/20…
Lucky to be at a firm that supports Health Sciences in such a robust way!
This article is also a very good argument for investors to look closely at the patents of the start-ups they are giving money to. They are key assets and need to be treated as such. That means a deep dive, not a casual glance. arstechnica.com/tech-policy/20…
Our Partner Nicole Stakleff understands how to protect patent term as well as anyone on the country! Important update Nicole & John Isacson!
This article is also a very good argument for investors to look closely at the patents of the start-ups they are giving money to. They are key assets and need to be treated as such. That means a deep dive, not a casual glance. arstechnica.com/tech-policy/20…
United States Trends
- 1. Lakers 41,1 B posts
- 2. Happy New Year 432 B posts
- 3. annabeth 8.711 posts
- 4. Lincoln Riley 3.530 posts
- 5. Pistons 9.553 posts
- 6. #PercyJackson 3.864 posts
- 7. #MiraclesAblazeDay2 21,2 B posts
- 8. #AlamoBowl N/A
- 9. #RIZIN 15 B posts
- 10. grover 2.224 posts
- 11. #LingOrmHNYatICONSIAM 2,15 Mn posts
- 12. Sasser 2.009 posts
- 13. Whale - Buy 2.587 posts
- 14. Ayton 3.184 posts
- 15. Maiava 1.121 posts
- 16. Olympus 4.419 posts
- 17. OutKast 1.146 posts
- 18. Tennessee 33,2 B posts
- 19. Jeremy Payne N/A
- 20. The 4D 224 B posts
Something went wrong.
Something went wrong.